Clinical Trial Update: Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole

View source ↗

Summary

This completed clinical trial evaluated overall survival in Japanese patients with HR+/HER2- advanced breast cancer treated with palbociclib plus letrozole. Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2025-12-09